BioPharma Credit (LON:BPCR) Trading Down 1.6% – What’s Next?

BioPharma Credit (LON:BPCRGet Free Report)’s stock price was down 1.6% on Monday . The stock traded as low as GBX 0.86 ($0.01) and last traded at GBX 0.86 ($0.01). Approximately 763,474 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 1,592,546 shares. The stock had previously closed at GBX 0.88 ($0.01).

BioPharma Credit Price Performance

The firm has a 50 day simple moving average of GBX 0.90 and a two-hundred day simple moving average of GBX 0.88. The stock has a market cap of £10.32 million, a price-to-earnings ratio of 10.80 and a beta of 0.22.

BioPharma Credit Increases Dividend

The business also recently announced a dividend, which will be paid on Tuesday, October 29th. Shareholders of record on Thursday, September 26th will be paid a $0.04 dividend. This is a positive change from BioPharma Credit’s previous dividend of $0.02. The ex-dividend date is Thursday, September 26th. This represents a yield of 4.26%. BioPharma Credit’s dividend payout ratio is presently 8,750.00%.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

Featured Stories

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.